Document is current
Any future updates will be listed below
-
Authors
Nguyen, Vi
Dolendo, Isabella
Uloko, Maria
Hsieh, Tung-Chin
Patel, Darshan https://orcid.org/0000-0001-6866-7889
- License Information
-
More Information
Article History
Received: 21 September 2022
Revised: 15 March 2023
Accepted: 24 March 2023
First Online: 15 April 2023
Competing interests
: VN has no disclosures. ID has no disclosures. MU has the following to disclose: Endo Pharmaceuticals—Advisor. TCH has the following to disclose: Boston Scientific—Advisor, consultant. Endo Pharmaceuticals—Advisor, consultant. DP has the following to disclose: Acerus Pharmaceuticals—Speakers Bureau, research grant. Apta Pharma—Equity interest. Endo Pharmaceuticals—Advisor
